PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination immunotherapy treatment effective before lung cancer surgery

Translational findings support combinations over monotherapy

Combination immunotherapy treatment effective before lung cancer surgery
2023-09-14
(Press-News.org) Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers at The University of Texas MD Anderson Cancer Center. 

The findings, published today in Cancer Discovery, were first presented at the American Association for Cancer Research (AACR) Annual Meeting 2022.    

The multicenter, randomized Phase II NeoCOAST clinical trial evaluated neoadjuvant durvalumab alone and in combination with each of the following novel immunotherapies: the anti-CD73 monoclonal antibody oleclumab, the anti-NKG2A monoclonal antibody monalizumab, and the anti-STAT3 antisense oligonucleotide danvatirsen. While the study was not statistically powered to compare arms, all combinations resulted in numerically higher major pathological response (MPR) rates than with durvalumab monotherapy.  

“This study builds on the growing evidence that combination immunotherapy has a role in the neoadjuvant setting for this patient population,” said Tina Cascone, MD., Ph.D., associate professor of Thoracic/Head and Neck Medical Oncology and lead author of the study. “Ultimately, we want to give patients a chance to live longer without their cancer returning.”  

The NeoCOAST trial adds to recent progress in neoadjuvant treatment for NSCLC, including the Phase II NEOSTAR study results published in Nature Medicine, which showed nivolumab and ipilimumab together induced higher responses than nivolumab alone, and the March 2022 approval of nivolumab combined with platinum-based chemotherapy from the Checkmate-816 study. The durvalumab combinations tested previously in the Phase II COAST trial were shown to be effective in unresectable stage III NSCLC, providing rationale for testing in earlier stage disease. 

The NeoCOAST study enrolled 84 patients with untreated, resectable (>2cm), stage I-IIIA NSCLC, between March 2019 and September 2020. Most patients were male (59.5%) and had a smoking history (89%). The median age was 67.5, and the racial breakdown was 89% white, 6% Black, 2% Asian and 2% other. Eighty-three patients received one 28-day cycle of neoadjuvant durvalumab alone or combined with another therapy. 

The primary endpoint was investigator-assessed MPR, defined as ≤10% residual viable tumor cells in the resected tumor tissue and sampled nodes at surgery. The investigators assessed pathological complete response (pCR), or complete disappearance of viable tumor cells, as a secondary endpoint. Exploratory endpoints included tumor, fecal and blood biomarkers. 

All combinations had numerically higher rates of MPR and pCR than monotherapy, and there were no statistically significant differences in responses between the combination arms: 

For the patients who received durvalumab monotherapy, MPR occurred in 11.1% and pCR in 3.7%, which is comparable to results from other monotherapy studies. 

MPR rates for combination therapy ranged from 19% (oleclumab) to 31.3% (danvatirsen), and pCR rates ranged from 9.5% (with oleclumab) to 12.5% (with danvatirsen). For combination therapy with monalizumab, MPR was 30% and pCR was 10%. 

The safety profile in the durvalumab monotherapy arm (treatment-related adverse events in 34.6% of patients) was similar to previously published data for anti-PD-1/PD-L1 antibodies. No new safety signals were identified with any of the combination regimens (treatment-related adverse events seen in 43.8% to 57.1% of patients). 

MPR was associated with baseline tumor PD-L1 expression of ≥1% in the oleclumab and monalizumab combination arms. In the oleclumab (anti-CD73) combination arm, high baseline CD73 expression was associated with pathological tumor regression, and treatment decreased CD73 expression on tumor cells, as previously observed in other studies. The oleclumab combination also was associated with greater natural killer (NK) and CD8 T cell density in the tumor center on treatment compared with baseline, suggesting an increased infiltration of effector cells in the tumor microenvironment. 

Updated translational studies on tumor tissues and blood samples revealed the impact of neoadjuvant treatment on the immune system. Transcriptome analysis on pre- and post-treatment samples showed an upregulation of genes associated with cytotoxicity, tertiary lymphoid structures and lymphocyte recruitment, all indicators of an activated immune response.  

The number of patients with no detected circulating tumor DNA (ctDNA) increased progressively from pre-to post-treatment and post-surgery follow up, highlighting the relationship between decreasing ctDNA levels and improved patient outcomes. Notably, surgery was the most effective intervention to result in clearance of ctDNA. Researchers also found an enrichment of beneficial bacteria in the gut microbiome of patients who achieved MPR. These bacteria were previously associated with a favorable immunotherapy response across several cancer types. 

“Our study is a testament to how clinical trials designed with translational findings in mind can support the rapid advancement of novel immune-based combinations to larger scale studies,” Cascone said. “I’m encouraged by these early findings as we work toward reducing the risk of recurrence and increasing cure rates for patients with early-stage non-small cell lung cancer.”   

Limitations of the study include the exploratory nature of the endpoints, small sample sizes and investigator-assessed outcomes without central review. 

Based on these results and the recent approval of neoadjuvant nivolumab plus chemotherapy, the team has launched a follow-up randomized clinical trial, NeoCOAST-2, with Cascone serving as the global principal investigator. The trial is now enrolling patients with resectable, stage IIA-IIIA NSCLC to receive neoadjuvant durvalumab combined with chemotherapy and either oleclumab or monalizumab or other novel and promising immuno-oncology (I-O) agents, followed by surgery and adjuvant durvalumab plus oleclumab or monalizumab or other I-O agents.  

The study was funded by AstraZeneca, which developed durvalumab, oleclumab and monalizumab (with Innate Pharma). Cascone reports a consulting/advisory role and contracted institutional support/research consulting for MedImmune/AstraZeneca. A full list of co-authors and disclosures can be found here. 

Read this press release in the MD Anderson Newsroom.

END

[Attachments] See images for this press release:
Combination immunotherapy treatment effective before lung cancer surgery Combination immunotherapy treatment effective before lung cancer surgery 2

ELSE PRESS RELEASES FROM THIS DATE:

Verbal nonsense reveals limitations of AI chatbots

Verbal nonsense reveals limitations of AI chatbots
2023-09-14
NEW YORK – The era of artificial-intelligence chatbots that seem to understand and use language the way we humans do has begun. Under the hood, these chatbots use large language models, a particular kind of neural network. But a new study shows that large language models remain vulnerable to mistaking nonsense for natural language. To a team of researchers at Columbia University, it’s a flaw that might point toward ways to improve chatbot performance and help reveal how humans process language.    In a paper published online today in Nature Machine Intelligence, ...

Revolutionizing brain monitoring and stimulation with thin-film neural electrodes

Revolutionizing brain monitoring and stimulation with thin-film neural electrodes
2023-09-14
 Flexible thin-film electrodes placed directly on brain tissue show promise for the diagnosis and treatment of epilepsy, as demonstrated recently by scientists at Tokyo Tech. Thanks to an innovative yet straightforward design, these durable electrodes accurately match the mechanical properties of brain tissue, leading to better performance during electrocorticography recordings and targeted neural stimulation. Measuring brain activity is a useful technique for diagnosing epilepsy and other neuropsychiatric disorders. Among the several approaches adopted, electroencephalography (EEG) is the least invasive. During EEG recordings, electrodes ...

Researchers present novel principle for nitric oxide-mediated signalling in blood vessels

2023-09-14
Although a simple molecule, nitric oxide is an important signal substance that helps to reduce blood pressure by relaxing the blood vessels. But how it goes about doing this has long been unclear. Researchers at Karolinska Institutet in Sweden now present an entirely novel principle that challenges the Nobel Prize-winning hypothesis that the substance signals in its gaseous form. Their findings are presented in the journal Nature Chemical Biology. That the simple molecule nitric oxide or nitrogen monoxide (NO) serves as a signal substance in many important physiological processes has been known for some time. For example, the discovery of the compound’s ...

Electrons from Earth may be forming water on the Moon

Electrons from Earth may be forming water on the Moon
2023-09-14
A team of researchers, led by a University of Hawai‘i (UH) at Mānoa planetary scientist, discovered that high energy electrons in Earth’s plasma sheet are contributing to weathering processes on the Moon's surface and, importantly, the electrons may have aided the formation of water on the lunar surface. The study was published today in Nature Astronomy.  Understanding the concentrations and distributions of water on the Moon is critical to understanding its formation and evolution, and to providing water resources for future human exploration. The new ...

New tool can reveal inequitable distribution of ‘healing’ green spaces

New tool can reveal inequitable distribution of ‘healing’ green spaces
2023-09-14
Areas in Vancouver with the greatest need for restorative nature often have the least exposure to it, according to a new UBC study published recently in Ambio. These neighbourhoods include Strathcona, downtown Vancouver, the West End, southern Sunset and Marpole. The researchers developed a new tool, the local restorative nature (LRN) index to assess spaces for the presence of qualities that promote mental well-being. While initially applied in Vancouver, the index can also be used in any urban landscape, according to lead author Dr. Tahia Devisscher, an assistant professor in the faculty of forestry. We sat down with Dr. Devisscher to discuss the study findings and ...

Many don’t know key facts about US Constitution, Annenberg study finds

Many don’t know key facts about US Constitution, Annenberg study finds
2023-09-14
PHILADELPHIA – Many Americans do not know what rights are protected under the First Amendment and a substantial number cannot name all three branches of government, according to the 2023 Annenberg Constitution Day Civics Survey. The Annenberg Public Policy Center’s annual, nationally representative survey finds that when U.S. adults are asked to name the specific rights guaranteed by the First Amendment to the Constitution, only one right is recalled by most of the respondents: Freedom of speech, ...

All work and no play will really make a dull life - new research reveals

2023-09-14
The study across three countries led by the Department of Psychology’s Dr Paul Hanel discovered people who prioritised achievement over enjoyment were less happy on the next day. Whereas those who aimed for freedom said they had a 13% increase in well-being, recording better sleep quality and life satisfaction. And participants who tried to relax and follow their hobbies recorded an average well-being boost of 8% and a 10% drop in stress and anxiety. Dr Hanel worked with colleagues at the University of Bath on the Journal of Personality-published study. For the first ...

New poll shows 77% of Massachusetts residents support $600 child & family tax credit

2023-09-14
Boston, MA – New polling data released late last week shows 77% of surveyed Massachusetts residents support a $600 state Child and Family Tax Credit. This polling confirms the popularity of the more generous Child and Family Tax Credit included in the House tax package, which is under consideration alongside the Senate tax bill by a bicameral conference committee. “The overwhelming support for a $600 tax credit per child matches up with the stories I have heard from families across my district, and the experiences of working Massachusetts families that they need more financial ...

New camera offers ultrafast imaging at a fraction of the normal cost

New camera offers ultrafast imaging at a fraction of the normal cost
2023-09-14
WASHINGTON — Capturing blur-free images of fast movements like falling water droplets or molecular interactions requires expensive ultrafast cameras that acquire millions of images per second. In a new paper, researchers report a camera that could offer a much less expensive way to achieve ultrafast imaging for a wide range of applications such as real-time monitoring of drug delivery or high-speed lidar systems for autonomous driving. “Our camera uses a completely new method to achieve high-speed imaging,” said Jinyang Liang from the Institut national de la recherche scientifique (INRS) ...

Peer-led patient navigation helps minoritized patients engage in their own mental healthcare

2023-09-14
INDIANAPOLIS – Research scientists led by Johanne Eliacin, PhD, of the U.S. Department of Veterans’ Affairs (VA) and Regenstrief Institute, have developed PARTNER-MH, an innovative, peer-led patient navigation program to support racially and ethnically minoritized veterans seeking mental healthcare, regardless of the types of mental health services needed or their mental health diagnoses. In two peer-reviewed published papers they report significant improvements in mental health outcomes and high participant satisfaction with the program. PARTNER-MH, developed for VA mental ...

LAST 30 PRESS RELEASES:

Polymer research aims to expand possibilities in sensor technology

New therapeutic avenues in bone repair

Socioeconomic status transition throughout life and risk of dementia

Climbing the social ladder slows dementia, Japanese study reveals

Researchers discover hidden step in dinosaur feather evolution

Studies reveal cell-by-cell changes caused when pig hearts and kidneys are transplanted into humans

SRI earns FDA Orphan Drug Designation for pancreatic cancer

A new gene-editing system tackles complex diseases

Tracking down toxic metals from tobacco smoke

Clarifying the cellular mechanisms underlying periodontitis with an improved animal model

Age, race impact AI performance on digital mammograms

SwRI leads courses at 2024 Society of Tribologists & Lubrication Engineers Annual Meeting

Hope for a cure for visceral leishmaniasis, an often fatal infectious disease

How AI helps programming a quantum computer

New research reveals that prehistoric seafloor pockmarks off the California coast are maintained by powerful sediment flows

AI can help improve ER admission decisions, Mount Sinai study finds

Matcha mouthwash inhibits bacteria that causes periodontitis

Oncology events in Poland solidify collaboration with NCCN

City of Hope awarded $5.4 million CIRM grant to create a stem cell laboratory and expand access to state-of-the-art disease models and technology among a diverse scientific community

Meeting preview: Hot topics at NUTRITION 2024

Study models how ketamine’s molecular action leads to its effects on the brain

A diaspora-based model of human migration

Black and Hispanic Americans experience wider temperature swings

Gamers say they hate ‘smurfing,’ but admit they do it

How immune cells recognize the abnormal metabolism of cancer cells

How plants mate for life and repel other suitors

3D printing robot uses AI machine learning for US Army research

Ruptured Achilles tendon shows faster repair amid plasma irradiation treatment

Screen time not the main factor making parent-child interactions worse, study finds

Improving the effectiveness of earthquake early warning systems

[Press-News.org] Combination immunotherapy treatment effective before lung cancer surgery
Translational findings support combinations over monotherapy